U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Childhood Acute Myeloid Leukemia

MedGen UID:
82981
•Concept ID:
C0278776
•
Neoplastic Process
Synonyms: Recurrent Childhood Acute Myeloblastic Leukemia; Recurrent Childhood Acute Myelogenous Leukemia; Recurrent Childhood AML; Recurrent Pediatric Acute Myeloblastic Leukemia; Recurrent Pediatric Acute Myelogenous Leukemia; Recurrent Pediatric Acute Myeloid Leukemia; Recurrent Pediatric AML; Relapsed Childhood Acute Myeloblastic Leukemia; Relapsed Childhood Acute Myelogenous Leukemia; Relapsed Childhood Acute Myeloid Leukemia; Relapsed Childhood AML; Relapsed Pediatric Acute Myeloblastic Leukemia; Relapsed Pediatric Acute Myelogenous Leukemia; Relapsed Pediatric Acute Myeloid Leukemia; Relapsed Pediatric AML

Definition

The reemergence of acute myeloid leukemia in childhood after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Childhood Acute Myeloid Leukemia

Professional guidelines

PubMed

Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan.
Yang YL, Jaing TH, Chen SH, Liu HC, Hung IJ, Lin DT, Yang CP, Peng CT, Lin KH, Hsiao CC, Jou ST, Chen JS, Lin MT, Wang SC, Chang TK, Huang FL, Cheng CN, Wu KH, Sheen JM, Chen SH, Lu MY, Hung GY, Yen HJ, Hsieh YL, Wang JL, Chang YH, Chang HH, Yeh TC, Weng TF, Hou JY, Chen BW, Chen RL, Wang LY, Ho WL, Chen YC, Cheng SN, Chao YH, Yang SH, Huang TH, Chou SW, Lin CY, Chen HY, Chao YY, Liang DC, Chang TT
Sci Rep 2021 Mar 15;11(1):5893. doi: 10.1038/s41598-021-85321-3. PMID: 33723338Free PMC Article
Treatment of Childhood Acute Myeloid Leukemia in Bulgaria.
Burnusuzov HA, Yordanova MN, Avramova BE, Yurukova NN, Bachvarov KN, Muchinova AB, Vlahova IH, Stoyanova AA, Mumdzhiev IN, Ivanova LR, Spasov NY, Peteva ET, Belcheva MI, Hristozova H, Spasova MI, Kaleva VI, Bobev D, Konstantinov DN
Folia Med (Plovdiv) 2018 Jun 1;60(2):234-240. doi: 10.1515/folmed-2017-0090. PMID: 30355812
Increased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse Treatment.
Vedi A, Mitchell R, Shanmuganathan S, Oswald C, Marshall GM, Trahair T, Sivarajasingam S, Ziegler DS
J Pediatr Hematol Oncol 2018 Oct;40(7):541-547. doi: 10.1097/MPH.0000000000001215. PMID: 29794644

Recent clinical studies

Etiology

Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study.
Steuber CP, Krischer J, Holbrook T, Camitta B, Land V, Sexauer C, Mahoney D, Weinstein H
J Clin Oncol 1996 May;14(5):1521-5. doi: 10.1200/JCO.1996.14.5.1521. PMID: 8622066

Therapy

Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study.
Steuber CP, Krischer J, Holbrook T, Camitta B, Land V, Sexauer C, Mahoney D, Weinstein H
J Clin Oncol 1996 May;14(5):1521-5. doi: 10.1200/JCO.1996.14.5.1521. PMID: 8622066

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...